We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Carnival Corporation Ltd
CCL
$38.7B
| $215K | 0.11% |
+7,056
| New | +$197K |
|
502
Forestar Group
FOR
$1.5B
| $215K | 0.11% |
+8,744
| New | +$223K |
|
503
Korea Electric Power
KEP
$14.9B
| $215K | 0.11% |
13,051
-10,280
| -44% | -$163K |
|
504
RPM International
RPM
$14.3B
| $215K | 0.11% |
2,065
-989
| -32% | -$107K |
|
505
Floor & Decor
FND
$6.14B
| $214K | 0.11% |
+3,521
| New | +$228K |
|
506
Universal Health Services
UHS
$10.1B
| $214K | 0.11% |
+983
| New | +$217K |
|
507
Ares Management
ARES
$28.8B
| $214K | 0.11% |
+1,325
| New | +$206K |
|
508
IDT Corp
IDT
$1.69B
| $213K | 0.11% |
4,166
-5,957
| -59% | -$299K |
|
509
McKesson
MCK
$104B
| $213K | 0.11% |
260
-7
| -3% | -$5.71K |
|
|
TPH
510
DELISTED
Tri Pointe Homes
TPH
| $213K | 0.11% |
+6,765
| New | +$220K |
|
511
Elbit Systems
ESLT
$38.4B
| $213K | 0.11% |
+368
| New | +$184K |
|
512
Vermilion Energy
VET
$1.59B
| $212K | 0.11% |
+25,399
| New | +$210K |
|
513
Crown Castle
CCI
$33.1B
| $212K | 0.11% |
+2,383
| New | +$219K |
|
514
Sportradar
SRAD
$4.38B
| $212K | 0.11% |
+8,900
| New | +$214K |
|
515
Ionis Pharmaceuticals
IONS
$9.14B
| $211K | 0.11% |
2,661
-926
| -26% | -$69.7K |
|
516
Clorox
CLX
$12.1B
| $210K | 0.11% |
+2,082
| New | +$226K |
|
517
AES
AES
$10.6B
| $210K | 0.11% |
+14,625
| New | +$206K |
|
518
Ford
F
$59.6B
| $210K | 0.11% |
15,980
+1,432
| +10% | +$18.5K |
|
|
LAND
519
Gladstone Land Corp
LAND
$366M
| $209K | 0.11% |
+22,859
| New | +$209K |
|
520
Guidewire Software
GWRE
$13.3B
| $209K | 0.11% |
+1,040
| New | +$230K |
|
521
Fulgent Genetics
FLGT
$558M
| $209K | 0.11% |
+7,951
| New | +$206K |
|
522
Nathan's Famous
NATH
$407M
| $208K | 0.11% |
+2,228
| New | +$224K |
|
523
Otis Worldwide
OTIS
$28B
| $208K | 0.11% |
+2,385
| New | +$213K |
|
|
PSTL
524
Postal Realty Trust
PSTL
$713M
| $208K | 0.11% |
12,880
-13,611
| -51% | -$209K |
|
525
DexCom
DXCM
$28.9B
| $208K | 0.11% |
+3,131
| New | +$202K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.